Provided by Tiger Trade Technology Pte. Ltd.

TC BioPharm

0.5000
0.0000
Volume:- -
Turnover:- -
Market Cap:256.50K
PE:-0.01
High:0.5000
Open:0.5000
Low:0.5000
Close:0.5000
52wk High:523.20
52wk Low:0.5000
Shares:512.99K
Float Shares:512.80K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-78.8143
EPS(LYR):-243.5587
ROE:-577.04%
ROA:-98.20%
PB:0.10
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
TC BioPharm
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.